{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:02:22Z","timestamp":1762866142935,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.msard.2012.12.004","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T19:30:35Z","timestamp":1359574235000},"page":"172-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Measures of visual pathway structure and function in MS: Clinical usefulness and role for MS trials"],"prefix":"10.1016","volume":"2","author":[{"given":"Kristin M.","family":"Galetta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Balcer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2012.12.004_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00155090","article-title":"Visual function in multiple sclerosis","volume":"73","author":"Ashworth","year":"1989","journal-title":"Documenta Ophthalmologica"},{"key":"10.1016\/j.msard.2012.12.004_bib2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000154521.40686.63","article-title":"Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis","volume":"64","author":"Baier","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib3","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1212\/01.WNL.0000094315.19931.90","article-title":"Contrast letter acuity as a visual component for the multiple sclerosis functional composite","volume":"61","author":"Balcer","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/135245850000600305","article-title":"New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis","volume":"6","author":"Balcer","year":"2000","journal-title":"Multiple Sclerosis"},{"issue":"suppl 3","key":"10.1016\/j.msard.2012.12.004_bib5","first-page":"S16","article-title":"Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity","volume":"74","author":"Balcer","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1212\/01.wnl.0000259521.14704.a8","article-title":"Natalizumab reduces visual loss in patients with relapsing multiple sclerosis","volume":"68","author":"Balcer","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00041327-200112000-00014","article-title":"Clinical outcome measures for research in multiple sclerosis","volume":"21","author":"Balcer","year":"2001","journal-title":"Journal of Neuro-Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMcp053247","article-title":"Clinical practice. Optic neuritis","volume":"354","author":"Balcer","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.msard.2012.12.004_bib9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archopht.121.4.484","article-title":"Scanning laser polarimetry of edematous and atrophic optic nerve heads","volume":"121","author":"Banks","year":"2003","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9394(03)00862-6","article-title":"Optic Neuritis Study Group. Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial","volume":"137","author":"Beck","year":"2004","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib11","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","article-title":"Visual acuity as an outcome measure in clinical trials of retinal diseases","volume":"114","author":"Beck","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib12","first-page":"284","article-title":"Hidden visual loss in optic neuropathy is revealed using Gabor patch contrast perimetry","volume":"4","author":"Bodis-Wollner","year":"1997","journal-title":"Clinical Neuroscience"},{"key":"10.1016\/j.msard.2012.12.004_bib13","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archneurol.2009.230","article-title":"Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis","volume":"66","author":"Burkholder","year":"2009","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib14","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archneur.65.9.1218","article-title":"Reproducibility of optical coherence tomography in multiple sclerosis","volume":"65","author":"Cettomai","year":"2008","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-2456(93)90015-6","article-title":"Design, methods, and conduct of the Optic Neuritis Treatment Trial","volume":"14","author":"Cleary","year":"1993","journal-title":"Controlled Clinical Trials"},{"key":"10.1016\/j.msard.2012.12.004_bib16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3129\/i10-063","article-title":"Using retinal architecture to help characterize multiple sclerosis patients","volume":"45","author":"Costello","year":"2010","journal-title":"Canadian Journal of Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/WNO.0b013e318221b434","article-title":"Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high precision manual estimation technique","volume":"31","author":"Davies","year":"2011","journal-title":"Journal of Neuro-Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib19","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awl074","article-title":"The contribution of demyelination to axonal loss in multiple sclerosis","volume":"129","author":"DeLuca","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.msard.2012.12.004_bib20","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/brain\/124.9.1813","article-title":"Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis","volume":"124","author":"Evangelou","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.msard.2012.12.004_bib21","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1212\/WNL.0b013e3181ff96f6","article-title":"Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis","volume":"75","author":"Filippi","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ana.21436","article-title":"Gray matter atrophy in multiple sclerosis: a longitudinal study","volume":"64","author":"Fisher","year":"2008","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.21423","article-title":"Gray matter atrophy is related to long-term disability in multiple sclerosis","volume":"64","author":"Fisniku","year":"2008","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archopht.1974.01010010097001","article-title":"Insidious atrophy of retinal nerve fibers in multiple sclerosis. Funduscopic identification in patients with and without visual complaints","volume":"92","author":"Fris\u00e9n","year":"1974","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1474-4422(06)70573-7","article-title":"Optical coherence tomography in multiple sclerosis","volume":"5","author":"Frohman","year":"2006","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archneurol.2007.10","article-title":"Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis","volume":"65","author":"Frohman","year":"2008","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1474-4422(05)00992-0","article-title":"The neuro-ophthalmology of multiple sclerosis","volume":"4","author":"Frohman","year":"2005","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ncpneuro0950","article-title":"Optical coherence tomography: a window into the mechanisms of multiple sclerosis","volume":"4","author":"Frohman","year":"2008","journal-title":"Nature Clinical Practice Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13311-010-0005-1","article-title":"Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration","volume":"8","author":"Galetta","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.msard.2012.12.004_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/WNO.0b013e318240204d","article-title":"Visual pathway loss in benign Multiple Sclerosis: a longitudinal study","volume":"32","author":"Galetta","year":"2012","journal-title":"Journal of Neuro-Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nic.2008.09.003","article-title":"Nonconventional optic nerve imaging in multiple sclerosis","volume":"19","author":"Glisson","year":"2009","journal-title":"Neuroimaging Clinics of North America"},{"key":"10.1016\/j.msard.2012.12.004_bib33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ophtha.2004.02.003","article-title":"Los Angeles Latino Eye Study Group. The impact of visual impairment on self-reported visual functioning in Latinos: the Los Angeles Latino Eye Study","volume":"111","author":"Globe","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ophtha.2004.02.003","article-title":"Los Angeles Latino Eye Study Group. The impact of visual impairment on self-reported visual functioning in Latinos: the Los Angeles Latino Eye Study","volume":"111","author":"Globe","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib35","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/brain\/awq080","article-title":"Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration","volume":"133","author":"Green","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.msard.2012.12.004_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/bmj.4.5893.661","article-title":"Visual evoked response in diagnosis of multiple sclerosis","volume":"4","author":"Halliday","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1016\/j.msard.2012.12.004_bib37","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/brain\/awq146","article-title":"A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials","volume":"133","author":"Henderson","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.msard.2012.12.004_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/jnnp.41.6.493","article-title":"Visual evoked responses and visual symptoms in multiple sclerosis","volume":"41","author":"Hoeppner","year":"1978","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.msard.2012.12.004_bib39","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1167\/iovs.04-0335","article-title":"Macular segmentation with optical coherence tomography","volume":"46","author":"Ishikawa","year":"2005","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1016\/j.msard.2012.12.004_bib40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/WCO.0b013e328334e99b","article-title":"Optical coherence tomography of the retina: applications in neurology","volume":"23","author":"Jindahra","year":"2010","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archophthalmol.2010.16","article-title":"Optic Neuritis Study Group. Visual field profile of optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial from baseline through 15 years","volume":"128","author":"Keltner","year":"2010","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00006982-199414050-00010","article-title":"Retinal pathologic changes in multiple sclerosis","volume":"14","author":"Kerrison","year":"1994","journal-title":"Retina"},{"key":"10.1016\/j.msard.2012.12.004_bib43","first-page":"632","article-title":"Contrast sensitivity loss in multiple sclerosis. Selectivity by eye, orientation, and spatial frequency measured with the evoked potential","volume":"25","author":"Kupersmith","year":"1984","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1016\/j.msard.2012.12.004_bib44","first-page":"E105","article-title":"The use of optical coherence tomography in neurology","volume":"6","author":"Lameril","year":"2009","journal-title":"Reviews in Neurological Diseases"},{"key":"10.1016\/j.msard.2012.12.004_bib45","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0002-9394(02)01337-5","article-title":"Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire","volume":"133","author":"Ma","year":"2002","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib46","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ajo.2007.02.022","article-title":"Los Angeles Latino Eye Study Group. Severity of visual field loss and health-related quality of life","volume":"143","author":"McKean-Cowdin","year":"2007","journal-title":"American Journal of Ophthalmology"},{"issue":"Suppl 3","key":"10.1016\/j.msard.2012.12.004_bib47","first-page":"S24","article-title":"Patient-centered outcomes: translating clinical efficacy into benefits on health-related quality of life","volume":"74","author":"Miller","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib48","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.2008.165449","article-title":"Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity","volume":"80","author":"Mowry","year":"2009","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.msard.2012.12.004_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0b013e3181aaea32","article-title":"Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis","volume":"73","author":"Naismith","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib50","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","article-title":"Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial","volume":"115","author":"Optic Neuritis Study Group","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib51","first-page":"2520","article-title":"Correlation between morphological and functional retinal impairment in multiple sclerosis patients","volume":"40","author":"Parisi","year":"1999","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1016\/j.msard.2012.12.004_bib52","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","article-title":"Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis","volume":"9","author":"Petzold","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ajo.2011.01.023","article-title":"One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis","volume":"152","author":"Pineles","year":"2011","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib54","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1212\/01.wnl.0000250267.85698.7a","article-title":"Gray matter involvement in multiple sclerosis","volume":"68","author":"Pirko","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib55","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archneurol.2010.148","article-title":"Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging","volume":"67","author":"Pitt","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib56","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ajo.2006.06.060","article-title":"Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25","volume":"142","author":"Raphael","year":"2006","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/104.2.333","article-title":"Contrast sensitivity, visual acuity and the discrimination of Snellen letters in multiple sclerosis","volume":"104","author":"Regan","year":"1981","journal-title":"Brain"},{"key":"10.1016\/j.msard.2012.12.004_bib58","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1167\/iovs.02-1100","article-title":"How sensitive to clinical change are ETDRS and logMAR visual acuity measurements?","volume":"44","author":"Rosser","year":"2003","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1016\/j.msard.2012.12.004_bib59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.410420318","article-title":"Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force","volume":"42","author":"Rudick","year":"1997","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ana.410400321","article-title":"Clinical outcomes assessment in multiple sclerosis","volume":"40","author":"Rudick","year":"1996","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib61","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/brain\/awq346","article-title":"Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography","volume":"134","author":"Saidha","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.msard.2012.12.004_bib62","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1442-9071.2009.02015.x","article-title":"Optical coherence tomography of the retina and optic nerve\u2014a review","volume":"37","author":"Sakata","year":"2009","journal-title":"Clinical and Experimental Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archneurol.2008.562","article-title":"Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway","volume":"66","author":"Sepulcre","year":"2009","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib64","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.neuroimage.2009.09.005","article-title":"A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions","volume":"49","author":"Shiee","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.msard.2012.12.004_bib65","doi-asserted-by":"crossref","unstructured":"Submacular Surgery Trials Research Group. Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Functioning Questionnaire (NEI-VFQ) SST Report Number 19. Ophthalmic Epidemiology 2007;14:205\u201315.","DOI":"10.1080\/09286580701502970"},{"key":"10.1016\/j.msard.2012.12.004_bib66","doi-asserted-by":"crossref","unstructured":"Submacular Surgery Trials Research Group. Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Functioning Questionnaire (NEI-VFQ) SST Report Number 19. Ophthalmic Epidemiology 2007;14:205\u201315.","DOI":"10.1080\/09286580701502970"},{"key":"10.1016\/j.msard.2012.12.004_bib67","doi-asserted-by":"crossref","unstructured":"Submacular Surgery Trials Research Group. Responsiveness of the National Eye Institute Visual Functioning Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization\u2014SST Report Number 1. Archives of Ophthalmology 2003;121:531\u20139.","DOI":"10.1001\/archopht.121.4.531"},{"key":"10.1016\/j.msard.2012.12.004_bib68","doi-asserted-by":"crossref","unstructured":"Submacular Surgery Trials Research Group. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization\u2014SST Report Number 1. Archives of Ophthalmology 2003;121:531\u20139.","DOI":"10.1001\/archopht.121.4.531"},{"key":"10.1016\/j.msard.2012.12.004_bib69","first-page":"1007","article-title":"Reproducibility of high-resolution optical coherence tomography in multiple sclerosis","volume":"4","author":"Syc","year":"2010","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2012.12.004_bib70","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.22005","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis","volume":"67","author":"Talman","year":"2010","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib71","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.ophtha.2009.05.025","article-title":"Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography","volume":"116","author":"Tan","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib72","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1212\/WNL.0b013e3181c3fd43","article-title":"Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials","volume":"73","author":"Thurtell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib73","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.msard.2012.12.004_bib74","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.20575","article-title":"Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis","volume":"58","author":"Trip","year":"2005","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib75","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9394(14)75429-7","article-title":"Contrast sensitivity and other vision tests in the Optic Neuritis Treatment Trial","volume":"121","author":"Trobe","year":"1996","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib76","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archopht.126.7.996","article-title":"The Optic Neuritis Treatment Trial: a definitive answer and profound impact with unexpected results","volume":"126","author":"Volpe","year":"2008","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib100","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.ophtha.2011.11.032","article-title":"Ganglion cell loss in relation to visual disability in multiple sclerosis","volume":"119","author":"Walter","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2012.12.004_bib77","first-page":"141","article-title":"Value of Pelli\u2013Robson contrast sensitivity chart for evaluation of visual system in multiple sclerosis patients","volume":"41","author":"Wender","year":"2007","journal-title":"Neurologica i Neurochirurgia Polska"},{"key":"10.1016\/j.msard.2012.12.004_bib78","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1212\/01.wnl.0000278387.15090.5a","article-title":"Relation of vision to global and regional brain MRI in multiple sclerosis","volume":"69","author":"Wu","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2012.12.004_bib79","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archneur.65.7.924","article-title":"Retinal imaging by laser polarimetry corroborates optical coherence tomography evidence of axonal degeneration in multiple sclerosis","volume":"65","author":"Zaveri","year":"2008","journal-title":"Archives of Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034812001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034812001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:36:43Z","timestamp":1761899803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034812001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S2211034812001526"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2012.12.004","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measures of visual pathway structure and function in MS: Clinical usefulness and role for MS trials","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2012.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}